Research Alliance Corporation IV consummated its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share, generating $75,000,000 in gross proceeds. Simultaneously, the company completed a private placement of 275,000 Class A ordinary shares to its sponsor, Research Alliance Holdings IV LLC, for $2,750,000. A total of $75,000,000 in net proceeds was deposited into a trust account for the benefit of public shareholders. Research Alliance Corporation IV is a blank check company formed for the purpose of effecting a business combination.

Research Alliance Corporation IV completed its initial public offering on July 14, 2026, selling 7,500,000 Class A ordinary shares at $10.00 per share, generating $75,000,000 in gross proceeds. Simultaneously, the company executed a private placement of 275,000 Class A ordinary shares to its sponsor at $10.00 per share, raising $2,750,000. Total net proceeds from the IPO and private placement, including a $2,250,000 underwriter deferred commission, were deposited into a trust account managed by Continental Stock Transfer & Trust Company. The company also appointed Alan Musso and John Maslowski to its board of directors and various committees. Research Alliance Corporation IV is a special purpose acquisition company (SPAC) formed to engage in an initial business combination.